Inherited metabolic disorders
Gaucher disease type 3
Gaucher disease type 3 is a GBA1-related lysosomal disorder with both systemic and slowly progressive neurologic manifestations. It can affect blood counts, liver, spleen, bones and eye movements or other nervous-system functions.
Other names and abbreviations
GD3 · GD III · type 3 Gaucher disease · Gaucher disease · Chronic neuronopathic Gaucher disease · Subacute neuronopathic Gaucher disease · Norrbottnian Gaucher disease
Where transplant fits
Allogeneic transplantation has an uncommon, highly selected role. It may improve blood and systemic disease, but evidence does not support presenting it as a dependable cure for the neurologic manifestations.
Treatment depends on the exact diagnosis, disease stage, prior treatment and the person’s health. These categories are not estimates of donor demand.
Treatment at a glance
- Who it affects
- Often recognized in childhood, with variable neurologic progression and systemic severity.
- Other treatment options
- Enzyme replacement treats important systemic manifestations. Neurologic and other organ-specific care remain necessary; treatment approvals and options vary by country and phenotype.
- Cells used for transplantation
- Allogeneic donor stem cells have been used in selected cases; this is not a routine modern graft pathway for every patient with type 3 disease.
Why the details matter
Type 3 is distinct from non-neuronopathic type 1 and rapidly progressive type 2 disease. Enzyme replacement has limited direct effect on central nervous system disease.
Questions to bring to your care team
What is the exact diagnosis or subtype? What is the goal of each treatment option? If transplant is being considered, why does it fit this situation, which cells would be used and what are the alternatives?
Sources and further reading
- Gaucher Disease
GeneReviews, University of Washington / NCBI Bookshelf · Accessed 2026-09-05 - Inborn Errors of Metabolism and Osteopetrosis
EBMT Handbook · 2024-04-11
Understanding can become action.
Some patients need a blood stem cell donor. Others receive different treatment. Wherever your interest began, you can help JBF reach more people who may be able to donate.
Explore the official registry serving where you live. It explains who can join, how registration works and what donation involves.
Find your official registryIf joining is not right for you, a gift to the Jada Bascom Foundation supports education, outreach and referrals to official registries.
Donate to JBFKeep learning
Why matching is hard: an interactive leukemia story
More in inherited metabolic disorders. Sharing a group does not mean sharing a treatment plan.
